Company Overview of Yamit Biotechnologies Ltd.
Yamit Biotechnologies, Ltd. engages in the research, development, and commercialization of therapies, utilizing antibodies targeting agents in combination with immuno-stimulator as immunotherapeutic agents for the treatment of various diseases. Its products include biological pharmaceutical for the treatment of dairy cattle infected with bovine mastitis; and Y-Complex for treating mastitis. The company was founded in 2001 and is based in Kiryat Shmone, Israel.
Kiryat Shmone, 11013
Founded in 2001
972 4 681 8815
972 4 681 8806
Key Executives for Yamit Biotechnologies Ltd.
Similar Private Companies By Industry
|Abital Pharma Pipelines Ltd.||Middle East/Africa|
|Active PX Ltd.||Middle East/Africa|
|Advanced Inhalation Technology Ltd.||Middle East/Africa|
|Angio B Ltd.||Middle East/Africa|
|Antaki Center for Herbal Medicine Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Yamit Biotechnologies Ltd., please visit yamit-bio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.